» Articles » PMID: 26322868

Patient-Specific Induced Pluripotent Stem Cells for Disease Modeling and Phenotypic Drug Discovery

Overview
Journal J Med Chem
Specialty Chemistry
Date 2015 Sep 1
PMID 26322868
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

In vitro cell models are invaluable tools for studying diseases and discovering drugs. Human induced pluripotent stem cells, particularly derived from patients, are an advantageous resource for generating ample supplies of cells to create unique platforms that model disease. This manuscript will review recent developments in modeling a variety of diseases (including their cellular phenotypes) with induced pluripotent stem cells derived from patients. It will also describe how researchers have exploited these models to validate drugs as potential therapeutics for these devastating diseases.

Citing Articles

Current advances and future prospects of cell reprogramming in progeroid syndromes.

Moledo-Nodar L, Celemin-Capaldi V, Ugalde A, Freije J Front Cell Dev Biol. 2025; 13:1546423.

PMID: 40046234 PMC: 11880271. DOI: 10.3389/fcell.2025.1546423.


A chemical approach facilitates CRISPRa-only human iPSC generation and minimizes the number of targeted loci required.

Abujarour R, Dinella J, Pribadi M, Fong L, Denholtz M, Gutierrez A Future Sci OA. 2024; 10(1):FSO964.

PMID: 38817352 PMC: 11137772. DOI: 10.2144/fsoa-2023-0257.


Differentiation of Pluripotent Stem Cells for Disease Modeling: Learning from Heart Development.

Chi C, Roland T, Song K Pharmaceuticals (Basel). 2024; 17(3).

PMID: 38543122 PMC: 10975450. DOI: 10.3390/ph17030337.


CRISPR and iPSCs: Recent Developments and Future Perspectives in Neurodegenerative Disease Modelling, Research, and Therapeutics.

Sen T, Thummer R Neurotox Res. 2022; 40(5):1597-1623.

PMID: 36044181 PMC: 9428373. DOI: 10.1007/s12640-022-00564-w.


Cell models for Down syndrome-Alzheimer's disease research.

Wu Y, West N, Bhattacharyya A, Wiseman F Neuronal Signal. 2022; 6(1):NS20210054.

PMID: 35449591 PMC: 8996251. DOI: 10.1042/NS20210054.